Your session is about to expire
← Back to Search
Rotator Interval Closure in Bankart Repair for Shoulder Dislocation
N/A
Waitlist Available
Research Sponsored by University of Western Ontario, Canada
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
At least one episode of demonstrated dislocation
Bankart lesion of the anterior glenoid labrum
Must not have
Posterior instability or the need for posterior surgical reconstruction
Presence of other pathologic conditions of the shoulder (excluding SLAP lesions)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3,6 weeks;3,6 months; 1,2 years
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether adding rotator interval closure to Bankart lesion repair improves outcomes. The investigators suspect that patients who undergo the additional procedure will have lower quality of life and less external rotation.
Who is the study for?
This trial is for individuals aged 15 to 50 who have had at least one shoulder dislocation and a specific injury called a Bankart lesion. They must not have other shoulder injuries, fractures, or significant bone lesions on the humeral head.
What is being tested?
The study compares two treatments for shoulder instability after dislocation: arthroscopic repair of the Bankart lesion alone versus the same procedure with additional closure of the rotator interval. The goal is to see if there's a difference in quality of life and arm movement.
What are the potential side effects?
Potential side effects may include decreased range of motion, particularly in external rotation, discomfort at the surgery site, and general risks associated with surgical procedures such as infection or reaction to anesthesia.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had at least one dislocation.
Select...
I have a specific shoulder injury known as a Bankart lesion.
Select...
I am between 15 and 50 years old.
Select...
I do not have any other injuries to my tendons or capsules.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I need surgery for instability at the back of my body.
Select...
I have a shoulder condition, but it's not a SLAP lesion.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3,6 weeks;3,6 months; 1,2 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3,6 weeks;3,6 months; 1,2 years
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Western Ontario Shoulder Instability Index
Secondary study objectives
4-Item Pain Intensity Measure
Range of Motion
Recurrence
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Arthroscopic Bankart Repair & Rotator Interval ClosureActive Control1 Intervention
Group II: Arthoscopic Bankart Repair aloneActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of Western Ontario, CanadaLead Sponsor
166 Previous Clinical Trials
319,216 Total Patients Enrolled
Dianne Bryant, PhDStudy DirectorThe University of Western Ontario
3 Previous Clinical Trials
140 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had at least one dislocation.I have a specific shoulder injury known as a Bankart lesion.I need surgery for instability at the back of my body.I have a shoulder condition, but it's not a SLAP lesion.I am between 15 and 50 years old.I do not have any other injuries to my tendons or capsules.
Research Study Groups:
This trial has the following groups:- Group 1: Arthroscopic Bankart Repair & Rotator Interval Closure
- Group 2: Arthoscopic Bankart Repair alone
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger